Awards and Accolades

Finalist E&Y 2009 (Pacific Region)

https://www.bcbusiness.ca/the-2009-runners-up

Industry Leaders Involved with iCo

Company ran an almost 200 patient Phase 2 study (in conjunction with JDRF) with 5 FTEs, an enormous undertaking

https://www.ophthalmologytimes.com/modern-medicine-feature-articles/ico-completes-phase-ii-ideal-dme-study-enrollment

Former iCo Board Members/Alumni

Current and Previous Deals

Ionis Pharmaceuticals, Cambridge Antibody Technology (CAT), Bill & Melinda Gates Foundation and Juvenile Diabetes Research Foundation (JDRF)